BAMCO Inc’s Ascendis Pharma A/S ASND Stock Holding History

BAMCO Inc’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$400K	Sell	1,500 -4,100	-73%	-$958K	﹤0.01%	322
2026 Q1	$1.28M	Hold	5,600	–	–	﹤0.01%	289
2025 Q4	$1.19M	Hold	5,600	–	–	﹤0.01%	295
2025 Q3	$1.11M	Buy	+5,600	New	+$1.04M	﹤0.01%	300
2023 Q2	–	Sell	-35,306	Closed	-$3.79M	–	345
2023 Q1	$3.79M	Hold	35,306	–	–	0.01%	275
2022 Q4	$4.31M	Buy	35,306 +27,806	+371%	+$3.23M	0.01%	280
2022 Q3	$774K	Buy	+7,500	New	+$711K	﹤0.01%	335
2022 Q1	–	Sell	-20,500	Closed	-$2.76M	–	392
2021 Q4	$2.76M	Buy	+20,500	New	+$3.05M	0.01%	339

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BAMCO Inc's ASND Position: Q2 2026 in Review

BAMCO Inc reduced its Ascendis Pharma A/S (ASND) stake by 73% in Q2 2026, selling an estimated $958K and leaving 1,500 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

BAMCO Inc first reported a position in ASND in Q4 2021 and has held it in 8 quarters since. The position peaked at $4.31M in Q4 2022. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

BAMCO Inc held 1,500 shares of Ascendis Pharma A/S worth $400K as of Q2 2026.
BAMCO Inc sold 4,100 Ascendis Pharma A/S shares in Q2 2026, an estimated $958K.
Ascendis Pharma A/S made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #322 holding.
BAMCO Inc first reported a position in Ascendis Pharma A/S in Q4 2021 and has held it in 8 quarters since.
BAMCO Inc's Ascendis Pharma A/S position peaked at $4.31M in Q4 2022.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.